Cibinqo 100 mg film-coated tablets, Placebo for Abrocitinib 100mg tablet clinical trials

B7451015 - A PHASE 3 MULTICENTER, LONG-TERM EXTENSION STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ABROCITINIB, WITH OR WITHOUT TOPICAL MEDICATIONS ADMINISTERED TO SUBJECTS AGED 12 YEARS AND OLDER WITH MODERATE TO SEVERE ATOPIC DERMATITIS

This study looks at a medicine called Abrocitinib (also known as Cibinqo) for people aged 12 and over with moderate to severe eczema. It wants to see if the medicine works well and is safe over a long time, sometimes used with regular skin creams.